Cargando…
Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin
Potential impacts from two methods of changing prescription drug ingredient reimbursement in the Wisconsin Medicaid program were estimated. Current reimbursement amounts were compared with those resulting from either direct prices for eight manufacturers' products and average wholesale price le...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192959/ https://www.ncbi.nlm.nih.gov/pubmed/10313098 |
_version_ | 1782338879329665024 |
---|---|
author | Kreling, David H. |
author_facet | Kreling, David H. |
author_sort | Kreling, David H. |
collection | PubMed |
description | Potential impacts from two methods of changing prescription drug ingredient reimbursement in the Wisconsin Medicaid program were estimated. Current reimbursement amounts were compared with those resulting from either direct prices for eight manufacturers' products and average wholesale price less 10.5 percent for other products or wholesaler cost plus 5.01 percent for all products. The resulting overall average ingredient cost reimbursement reductions were 6.64 percent ($0.56 per prescription) and 6.94 percent ($0.59 per prescription) for the two methods, respectively. The results should be viewed from the perspective of both program savings and reduced pharmacists' revenues. |
format | Online Article Text |
id | pubmed-4192959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | CENTERS for MEDICARE & MEDICAID SERVICES |
record_format | MEDLINE/PubMed |
spelling | pubmed-41929592014-11-04 Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin Kreling, David H. Health Care Financ Rev Research Article Potential impacts from two methods of changing prescription drug ingredient reimbursement in the Wisconsin Medicaid program were estimated. Current reimbursement amounts were compared with those resulting from either direct prices for eight manufacturers' products and average wholesale price less 10.5 percent for other products or wholesaler cost plus 5.01 percent for all products. The resulting overall average ingredient cost reimbursement reductions were 6.64 percent ($0.56 per prescription) and 6.94 percent ($0.59 per prescription) for the two methods, respectively. The results should be viewed from the perspective of both program savings and reduced pharmacists' revenues. CENTERS for MEDICARE & MEDICAID SERVICES 1989 /pmc/articles/PMC4192959/ /pubmed/10313098 Text en |
spellingShingle | Research Article Kreling, David H. Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin |
title | Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin |
title_full | Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin |
title_fullStr | Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin |
title_full_unstemmed | Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin |
title_short | Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin |
title_sort | assessing potential prescription reimbursement changes: estimated acquisition costs in wisconsin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192959/ https://www.ncbi.nlm.nih.gov/pubmed/10313098 |
work_keys_str_mv | AT krelingdavidh assessingpotentialprescriptionreimbursementchangesestimatedacquisitioncostsinwisconsin |